Open AccessGuillain‐Barré syndrome after SARS‐CoV‐2 infection
Author(s) -
Kajita Mikiya,
Sato Masamichi,
Iizuka Yutaka,
Mashimo Yamato,
Furuta Natsumi,
Kakizaki Satoru
Publication year - 2022
Publication title -
journal of general and family medicine
Language(s) - English
Resource type - Journals
ISSN - 2189-7948
DOI - 10.1002/jgf2.481
Subject(s) - medicine , guillain barre syndrome , covid-19 , virology , betacoronavirus , immunology , outbreak , infectious disease (medical specialty) , disease
Abstract We herein report a case of Guillain‐Barré syndrome (GBS) after SARS‐CoV‐2 infection. The patient was a close contact with a SARS‐CoV‐2 patient. Initially, she did not have any symptoms and quarantined at a hotel. Dysgeusia and olfactory abnormality appeared at day 6 after testing positive for infection and disappeared by day 9. Subsequently, the patient developed numbness of the arms and legs, difficulty walking, and dyspnea and was referred to our hospital. Her clinical examination showed generalized weakness and hyporeflexia. A cerebrospinal fluid analysis showed albuminocytological dissociation. Her nerve conduction studies were consistent with demyelinating polyneuropathy. Intravenous immunoglobulin was administered based on a diagnosis of GBS.